RecruitingNCT04577248
The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Sponsor
Deutsches Herzzentrum Muenchen
Enrollment
5,000 participants
Start Date
Sep 15, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
Eligibility
Min Age: 18 YearsMax Age: 110 Years
Inclusion Criteria4
- Age above 18 years and consentable
- Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
- Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
- Written informed consent
Exclusion Criteria1
- Patient's inability to fully cooperate with the protocol
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEedge-to-edge valve repair
edge-to-edge valve repair
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04577248
Related Trials
The TRICURE EU Pivotal Study
NCT065814718 locations
The TRICURE EFS Study
NCT065069429 locations
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
NCT0324264285 locations
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
NCT0505103361 locations
Prospective Study of Lead-associated Tricuspid Regurgitation in Patients Undergoing New Transvalvular Lead Insertion
NCT073420361 location